Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K101453
    Date Cleared
    2011-07-21

    (422 days)

    Product Code
    Regulation Number
    872.3930
    Panel
    Dental
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    OBI BIOLOGICS, INC.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Vitala™ Resorbable Natural Collagen Membrane is intended for use during the process of guided bone regeneration (GBR) and guided tissue regeneration (GTR) as a biodegradable barrier for:

    • Simultaneous use with implants;
    • Augmentation around implants placed in immediate extraction sockets;
    • Augmentation around implants placed in delayed extraction sockets;
    • Localized ridge augmentation for later implantation;
    • Alveolar ridge reconstruction for prosthetic treatment;
    • Alveolar ridge preservation consequent to tooth extraction;
    • Filling of bone defects after root resection, cystectomy, removal of retained teeth;
    • Over the window in lateral window sinus elevation procedures;
    • Furcation defects in multi-rooted teeth;
    • Treatment of recession defects, together with coronally positioned flap;
    • In implants with vertical bone loss due to infection, only with satisfactory debridement and implant surface disinfection;
    • Guided bone regeneration in dehiscence defects; and
    • Guided tissue regeneration in periodontal defects.
    Device Description

    Vitala™ Resorbable Natural Collagen Membrane is a natural collagen membrane sourced from veterinary certified pigs. Vitala™ Resorbable Natural Collagen Membrane, minimally manipulated without further cross-linking, is sterilized in a double tray package configuration via E-beam irradiation.

    AI/ML Overview

    The provided text describes a 510(k) premarket notification for a medical device called "Vitala™ Resorbable Natural Collagen Membrane." This submission is focused on demonstrating substantial equivalence to predicate devices, not on a new clinical study to prove adherence to specific acceptance criteria. Therefore, most of the requested information about acceptance criteria, test sets, expert adjudication, and study designs (MRMC, standalone) is not present in this document.

    Here's an analysis of the available information:

    1. A table of acceptance criteria and the reported device performance

    The document does not present specific quantitative acceptance criteria or performance metrics in the way a clinical study or performance testing report would. Instead, it relies on comparison to predicate devices, arguing "substantial equivalence" based on similar properties and characteristics.

    The table implicitly shows "acceptance" of the Vitala™ device by demonstrating similarities to established predicate devices across various attributes. The acceptance is that the device is "substantially equivalent" to the predicates, meaning it performs as safely and effectively.

    PropertyAcceptance Criteria (Implied by Predicate Performance)Reported Device Performance (Vitala™)
    Models/SizesSimilar to predicate devices13mm x 25mm, 15mm x 20mm, 20mm x 30mm, 30mm x 40mm, 40mm x 50mm
    Intended UseSimilar to predicate devicesWide range of GBR/GTR applications, extensively listed and overlapping with predicates.
    Basic DesignIncorporates same basic design as predicatesYes
    Operating PrincipleUtilizes the same operating principle as predicatesCell-occlusive, Implantable, Resorbable, Hemostatic
    MaterialsIncorporates similar materials to predicatesYes, porcine collagen
    Sterilization ProcessIdentical to predicatesIrradiation
    BiocompatibilityBiocompatibleYes
    Non-pyrogenicityNon-pyrogenicYes

    2. Sample size used for the test set and the data provenance

    No test set data is provided in this 510(k) submission. The document relies on a comparison table to predicate devices. For 510(k) submissions, in vitro testing or existing biocompatibility data for the material may be submitted, but often detailed clinical study sample sizes are not required if substantial equivalence can be shown through other means (e.g., comparison of materials, manufacturing processes, and indications for use). This document does not detail any specific studies with sample sizes.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    Not applicable. No test set requiring expert ground truth establishment is described.

    4. Adjudication method for the test set

    Not applicable. No test set described.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This is a collagen membrane, not an AI or imaging device. There is no mention of MRMC studies or AI assistance.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This is a collagen membrane, not an algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    The "ground truth" for this 510(k) submission is effectively the established safety and efficacy of the predicate devices as determined by their previous regulatory clearances and real-world performance. The new device demonstrates "substantial equivalence" to these established benchmarks.

    8. The sample size for the training set

    Not applicable. This is not an AI/machine learning device.

    9. How the ground truth for the training set was established

    Not applicable. This is not an AI/machine learning device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1